Vitiligo

From Anvita Health Wiki

Jump to: navigation, search

Contents

Etiology

  • thyroid disease

Epidemiology

  • incidence is approximately 1%
  • affects both sexes equally
  • more noticeable in dark-skinned individuals
  • peak incidence between 10-30 years

Pathology

Genetics

Clinical-manifestations

  • 1 mm to several cm in diameter
  • generally white, but may be off-white or tan in color
  • circular or oval in shape, may have scalloped edges
  • accentuated by viewing with Wood's lamp, especially in light-skinned patients
  • focal, segmental or generalized in distribution
  • generalized vitiligo tends to occur in a symmetric pattern
  • common sites include
  • body folds
  • other skin manifestations

Laboratory

Diagnostic-procedures

Differential-diagnosis

Management

  • primarily of cosmetic & social concern
  • tends to be stable initially, then progresses over several years
  • untreated vitiligo usually remains for life, but some individuals spontaneously repigment depigmented areas
  • sunscreens ( SPF > 30) will diminish pigmentation of adjacent areas which make the vitiligo more noticeable
  • cosmetics may provide good results
  • pharmacologic agents
  • hydrocortisone 1% or 2.5% on face & skin folds
  • more potent steroids elsewhere
  • use interrupted schedule if steroids are used for more than 6-8 weeks to reduce risk of steroid atrophy
  • topical PUVA photochemotherapy or oral psoralen for more extensive disease
  • permanent, uniform bleaching of remaining normal skin
  • may be useful for patients with extensive disease

More General Terms

Additional Terms

Internet Database

OMIM: 193200

References

  1. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 952-53
  2. Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 296
  3. Medical Knowledge Self Assessment Program (MKSAP) 15, American College of Physicians, Philadelphia 2009
  4. NIH Institute and Center Resources [1]
  5. National Guideline Clearinghouse Guideline for the diagnosis and management of vitiligo. British Association of Dermatologists ngc-guideline: [2]